Page last updated: 2024-10-24

carmustine and Chronic Disease

carmustine has been researched along with Chronic Disease in 1 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chuang, RY1
Laszlo, J1
Keller, P1

Other Studies

1 other study available for carmustine and Chronic Disease

ArticleYear
Effects of nitrosoureas on human DNA polymerase activities from acute and chronic granulocytic leukemia cells.
    Biochimica et biophysica acta, 1976, Apr-02, Volume: 425, Issue:4

    Topics: Acute Disease; Carmustine; Chronic Disease; DNA Nucleotidyltransferases; Granulocytes; Humans; Kinet

1976